Rhumbline Advisers Brainstorm Cell Therapeutics Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.01 - $4.01 $84,987 - $113,222	-28,235 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.99 - $17.73 $7,860 - $34,928	1,970 Added 7.5%	28,235 $128,000
Q3 2020 Nov 12, 2020	SELL	$11.19 - $16.92 $29,541 - $44,668	-2,640 Reduced 9.13%	26,265 $444,000
Q2 2020 Aug 13, 2020	BUY	$4.42 - $12.66 $127,760 - $365,937	28,905 New	28,905 $324,000

12.3M

169K

30.6K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $8.03M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.